Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer
2011-01-01 Di Legge, Alessia; Trivellizzi Ilaria, Nausica; Moruzzi Maria, Cristina; Pesce, Adele; Scambia, Giovanni; Lorusso, D
Role of gemcitabine in ovarian cancer treatment
2006-01-01 Lorusso, D; Di Stefano, A.; Fanfani, F.; Scambia, G.
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study
2008-01-01 Pignata, Sandro; Breda, Enrico; Scambia, Giovanni; Pisano, Carmela; Zagonel, Vittorina; Lorusso, D; Greggi, Stefano; De Vivo, Rocco; Ferrandina, Gabriella; Gallo, Ciro; Perrone, Francesco
Is this efficacy in partially platinum-sensitive patients observed at any relapse?
2013-01-01 Sehouli, J; del Campo, Jm; Lorusso, D
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
2019-01-01 Harter, P; Sehouli, J; Lorusso, D; Reuss, A; Vergote, I; Marth, C; Kim, Jw; Raspagliesi, F; Lampe, B; Aletti, G; Meier, W; Cibula, D; Mustea, A; Mahner, S; Runnebaum, Ib; Schmalfeldt, B; Burges, A; Kimmig, R; Scambia, G; Greggi, S; Hilpert, F; Hasenburg, A; Hillemanns, P; Giorda, G; von Leffern, I; Schade-Brittinger, C; Wagner, U; du Bois, A.
Surgical Management and Prognostic Factors of Vulvovaginal Melanoma
2016-01-01 Ditto, A; Bogani, G; Martinelli, F; Di Donato, V; Laufer, J; Scasso, S; Chiappa, V; Signorelli, M; Indini, A; Lorusso, D; Raspagliesi, F
Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift
2015-01-01 Papadia, A; Bellati, F; Ditto, A; Bogani, G; Gasparri, Ml; Di Donato, V; Martinelli, F; Lorusso, D; Benedetti-Panici, P; Raspagliesi, F
Invasive Paget Disease of the Vulva.
2018-01-01 Borghi, C; Bogani, G; Ditto, A; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Perotto, S; Leone Roberti Maggiore, U; Recalcati, D; Lorusso, D; Raspagliesi, F.
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome
2006-01-01 Ferrandina, Gabriella; Distefano, Mariagrazia; Smaniotto, Daniela; Morganti, Alessio; Paglia, Amelia; Macchia, Gabriella; Corvari, Barbara; Lorusso, D; Scambia, Giovanni; RI Macchia, Gabriella/H-2987-2012
Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia.
2017-01-01 Bogani, G; Martinelli, F; Ditto, A; Taverna, F; Lombardo, C; Signorelli, M; Chiappa, V; Leone Roberti Maggiore, U; Fontanella, C; Sabatucci, I; Borghi, C; Recalcati, D; Indini, A; Lorusso, D; Raspagliesi, F.
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients - May a new treatment schedule improve toxicity profile?
2004-01-01 Lorusso, D; Naldini, A; Testa, A; D'Agostino, G; Scambia, G; Ferrandina, G
Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor
2013-01-01 Raspagliesi, F; Ditto, A; Martinelli, F; Haeusler, E; Lorusso, D
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
2019-01-01 Indini, A; Di Guardo, L; Cimminiello, C; Lorusso, D; Raspagliesi, F; Del Vecchio, M.
Fertility sparing surgery in early stage epithelial ovarian cancer
2014-01-01 Ditto, A; Martinelli, F; Lorusso, D; Haeusler, E; Carcangiu, M; Raspagliesi, F
What do you usually do in your hospital when a patient develops hypersensitivity to platinum?
2013-01-01 del Campo, Jm; Sehouli, J; Lorusso, D
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer
2019-01-01 Lorusso, D; Hilpert, F; González Martin, A; Rau, J; Ottevanger, P; Greimel, E; Lück, Hj; Selle, F; Colombo, N; Kroep, Jr; Mirza, Mr; Berger, R; Pardo, B; Grischke, Em; Berton-Rigaud, D; Martinez-Garcia, J; Vergote, I; Redondo, A; Cardona, A; Bastière-Truchot, L; du Bois, A; Kurzeder, C; PENELOPE trial, Investigators.
Gemcitabine (GEM) and pegylated liposomal doxorubicin (PLD) in recurrent metastatic breast carcinoma: A phase II study
2005-01-01 Ferrandina, G.; Adamo, V.; Ferrau, F.; Condemi, G.; Di Lullo, L.; Rossello, R.; Lorusso, D; Garipoli, C.; Scambia, G.
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer
2001-01-01 Greggi, S; Salerno, Mg; D'Agostino, G; Ferrandina, G; Lorusso, D; Manzione, L; Mancuso, S; Scambia, G
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial
2019-01-01 Lorusso, D; Ferrandina, G; Colombo, N; Pignata, S; Pietragalla, A; Sonetto, C; Pisano, C; Lapresa, Mt; Savarese, A; Tagliaferri, P; Lombardi, D; Cinieri, S; Breda, E; Sabatucci, I; Sabbatini, R; Conte, C; Cecere, Sc; Maltese, G; Scambia, G.
Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience
2017-01-01 Raspagliesi, F; Bogani, G; Spinillo, A; Ditto, A; Bogliolo, S; Casarin, J; Leone Roberti Maggiore, U; Martinelli, F; Signorelli, M; Gardella, B; Chiappa, V; Scaffa, C; Ferrero, S; Cromi, A; Lorusso, D; Ghezzi, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer | 1-gen-2011 | Di Legge, Alessia; Trivellizzi Ilaria, Nausica; Moruzzi Maria, Cristina; Pesce, Adele; Scambia, Giovanni; Lorusso, D | |
| Role of gemcitabine in ovarian cancer treatment | 1-gen-2006 | Lorusso, D; Di Stefano, A.; Fanfani, F.; Scambia, G. | |
| A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study | 1-gen-2008 | Pignata, Sandro; Breda, Enrico; Scambia, Giovanni; Pisano, Carmela; Zagonel, Vittorina; Lorusso, D; Greggi, Stefano; De Vivo, Rocco; Ferrandina, Gabriella; Gallo, Ciro; Perrone, Francesco | |
| Is this efficacy in partially platinum-sensitive patients observed at any relapse? | 1-gen-2013 | Sehouli, J; del Campo, Jm; Lorusso, D | |
| A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms | 1-gen-2019 | Harter, P; Sehouli, J; Lorusso, D; Reuss, A; Vergote, I; Marth, C; Kim, Jw; Raspagliesi, F; Lampe, B; Aletti, G; Meier, W; Cibula, D; Mustea, A; Mahner, S; Runnebaum, Ib; Schmalfeldt, B; Burges, A; Kimmig, R; Scambia, G; Greggi, S; Hilpert, F; Hasenburg, A; Hillemanns, P; Giorda, G; von Leffern, I; Schade-Brittinger, C; Wagner, U; du Bois, A. | |
| Surgical Management and Prognostic Factors of Vulvovaginal Melanoma | 1-gen-2016 | Ditto, A; Bogani, G; Martinelli, F; Di Donato, V; Laufer, J; Scasso, S; Chiappa, V; Signorelli, M; Indini, A; Lorusso, D; Raspagliesi, F | |
| Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift | 1-gen-2015 | Papadia, A; Bellati, F; Ditto, A; Bogani, G; Gasparri, Ml; Di Donato, V; Martinelli, F; Lorusso, D; Benedetti-Panici, P; Raspagliesi, F | |
| Invasive Paget Disease of the Vulva. | 1-gen-2018 | Borghi, C; Bogani, G; Ditto, A; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Perotto, S; Leone Roberti Maggiore, U; Recalcati, D; Lorusso, D; Raspagliesi, F. | |
| Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome | 1-gen-2006 | Ferrandina, Gabriella; Distefano, Mariagrazia; Smaniotto, Daniela; Morganti, Alessio; Paglia, Amelia; Macchia, Gabriella; Corvari, Barbara; Lorusso, D; Scambia, Giovanni; RI Macchia, Gabriella/H-2987-2012 | |
| Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia. | 1-gen-2017 | Bogani, G; Martinelli, F; Ditto, A; Taverna, F; Lombardo, C; Signorelli, M; Chiappa, V; Leone Roberti Maggiore, U; Fontanella, C; Sabatucci, I; Borghi, C; Recalcati, D; Indini, A; Lorusso, D; Raspagliesi, F. | |
| Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients - May a new treatment schedule improve toxicity profile? | 1-gen-2004 | Lorusso, D; Naldini, A; Testa, A; D'Agostino, G; Scambia, G; Ferrandina, G | |
| Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor | 1-gen-2013 | Raspagliesi, F; Ditto, A; Martinelli, F; Haeusler, E; Lorusso, D | |
| Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience | 1-gen-2019 | Indini, A; Di Guardo, L; Cimminiello, C; Lorusso, D; Raspagliesi, F; Del Vecchio, M. | |
| Fertility sparing surgery in early stage epithelial ovarian cancer | 1-gen-2014 | Ditto, A; Martinelli, F; Lorusso, D; Haeusler, E; Carcangiu, M; Raspagliesi, F | |
| What do you usually do in your hospital when a patient develops hypersensitivity to platinum? | 1-gen-2013 | del Campo, Jm; Sehouli, J; Lorusso, D | |
| Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer | 1-gen-2019 | Lorusso, D; Hilpert, F; González Martin, A; Rau, J; Ottevanger, P; Greimel, E; Lück, Hj; Selle, F; Colombo, N; Kroep, Jr; Mirza, Mr; Berger, R; Pardo, B; Grischke, Em; Berton-Rigaud, D; Martinez-Garcia, J; Vergote, I; Redondo, A; Cardona, A; Bastière-Truchot, L; du Bois, A; Kurzeder, C; PENELOPE trial, Investigators. | |
| Gemcitabine (GEM) and pegylated liposomal doxorubicin (PLD) in recurrent metastatic breast carcinoma: A phase II study | 1-gen-2005 | Ferrandina, G.; Adamo, V.; Ferrau, F.; Condemi, G.; Di Lullo, L.; Rossello, R.; Lorusso, D; Garipoli, C.; Scambia, G. | |
| Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer | 1-gen-2001 | Greggi, S; Salerno, Mg; D'Agostino, G; Ferrandina, G; Lorusso, D; Manzione, L; Mancuso, S; Scambia, G | |
| Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial | 1-gen-2019 | Lorusso, D; Ferrandina, G; Colombo, N; Pignata, S; Pietragalla, A; Sonetto, C; Pisano, C; Lapresa, Mt; Savarese, A; Tagliaferri, P; Lombardi, D; Cinieri, S; Breda, E; Sabatucci, I; Sabbatini, R; Conte, C; Cecere, Sc; Maltese, G; Scambia, G. | |
| Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience | 1-gen-2017 | Raspagliesi, F; Bogani, G; Spinillo, A; Ditto, A; Bogliolo, S; Casarin, J; Leone Roberti Maggiore, U; Martinelli, F; Signorelli, M; Gardella, B; Chiappa, V; Scaffa, C; Ferrero, S; Cromi, A; Lorusso, D; Ghezzi, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26879
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269083
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS227
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE182
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19160
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24626
- reserved1362
- open891